kidney disease glp 1 Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Glucagon-like peptide-1 receptor agonists in

[DOI] [PubMed] [Google Scholar] 24.Davidson J

PMID: 25321323

We can't predict where the next breakthrough will come from, but we can make breakthroughs possibleWith the July 13 OMB public comment deadline approaching, we encourage you to read this newest blog post and spend a few minutes talking with your friends, family members, neighbors about why federal investment in research matters to them.

Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, Chloride, Acetate, (-)- Nootropic Agents Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias